P21 (Without Adamantane)

P21 peptide, also known as CNTF-derived peptide or Ac-DGGL-NH2, represents a cognitive classification research compound that has garnered significant attention in neuroscience laboratories. This tetrapeptide mimics the neurotrophic effects of brain-derived neurotrophic factor (BDNF) through a selective mechanism that binds to the TrkB receptor whilst activating downstream PI3K/Akt and MAPK/ERK signalling pathways. Unlike full-length BDNF, P21 demonstrates efficient blood-brain barrier penetration in research models, making it particularly valuable for neurological studies. Crucially, P21 does not activate the p75NTR receptor, which is associated with apoptotic signalling, providing a selective approach to neurotrophin research without unwanted pro-apoptotic effects. Studies indicate that P21 promotes neurogenesis specifically in the dentate gyrus of the hippocampus in research models. Animal studies have demonstrated robust neurogenesis and cognitive improvement, with P21 showing enhanced spatial learning and memory capabilities in aged rat models. The compound's derivation from Cerebrolysin research has provided valuable insights into its mechanism of action. The evidence grade for P21 is classified as C, with animal studies showing promising results for hippocampal neurogenesis and spatial memory enhancement. However, no completed human clinical trials are currently available, positioning P21 as an important research tool for investigating cognitive mechanisms and neuroplasticity in laboratory settings.